AHA Scientific Sessions 2025 Abstract
Efficacy and Safety of a Novel AAV FXN Gene Therapy (SGT-212) for the Treatment of Friedreich’s Ataxia
Experiments in animalsInterventions
The paper
Solid Biosciences
AHA Scientific Sessions 2025 Abstract, 3 Nov 2025
Presented at AHA Scientific Sessions 2025, abstract 4366785
